| Immune responses associated with protection induced by chemoattenuated PfSPZ vaccine in malaria-naive Europeans YD Mouwenda, SP Jochems, V Van Unen, MEB Ongwe, ... JCI insight 9 (9), 2024 | | 2024 |
| Bifidobacteria compensate for genotype in lactose tolerance L Fitzstevens, X Liu, A Ruaud, VT Schmidt, M Mbong Ngwese, ... 75th Mosbacher Kolloquium" The Microbiome-from Understanding to Modulation", 2024 | | 2024 |
| Safety and efficacy of dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised … R González, T Nhampossa, G Mombo-Ngoma, J Mischlinger, M Esen, ... The Lancet Infectious Diseases, 2024 | 4 | 2024 |
| OA-99 Evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: a multi-centre … R González, T Nhampossa, G Mombo-Ngoma, J Mischlinger, M Esen, ... BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
| Bifidobacteria confer microbiome-acquired lactose tolerance in genetically lactase-non persistent humansrts L Fitzstevens, X Liu, A Ruaud, V Schmidt, M Mbong, J Rauch, ... 3rd International Conference Controlling Microbes to Fight Infections (CMFI …, 2023 | | 2023 |
| Vaccine-induced fevers are associated with diet and the gut microbiome K Huus, M Esen, S Dauser, S Loum, ND Youngblut, A Tyakht, R Ley | | 2023 |
| Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines J Van Coillie, T Pongracz, T Šuštić, W Wang, J Nouta, M Le Gars, ... Iscience 26 (9), 2023 | 4 | 2023 |
| The exception that proves the rule: Virulence gene expression at the onset of Plasmodium falciparum blood stage infections JS Wichers-Misterek, R Krumkamp, J Held, H von Thien, I Wittmann, ... PLoS Pathogens 19 (6), e1011468, 2023 | 3 | 2023 |
| Fever-microbiome interactions during human vaccination: The µHEAT study KE Huus, M Esen, J Gabor, JM Gaile, WA Fleischmann, G Smeenk, ... Cell Symposia: Infection Biology in the Age of the Microbiome, 2023 | | 2023 |
| A novel multi-antigenic parapoxvirus-based vaccine demonstrates efficacy in protecting hamsters and non-human primates against SARS-CoV-2 challenge A Reguzova, M Sigle, F Pagallies, F Salomon, HJ Rziha, ... | 4 | 2023 |
| Prevalence and impact of SARS-CoV-2 infection on maternal and infant health in African populations: protocol of a multicentre prospective cohort study (MA-CoV project) A Figueroa-Romero, A Mendes, G Mombo-Ngoma, J Mischlinger, M Esen, ... BMJ open 13 (5), e067083, 2023 | 2 | 2023 |
| First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2 MJ Smit, AF Sander, MBPA Ariaans, C Fougeroux, C Heinzel, R Fendel, ... The Lancet Microbe 4 (3), e140-e148, 2023 | 14 | 2023 |
| Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity CM Zu Natrup, A Tscherne, C Dahlke, M Ciurkiewicz, DL Shin, A Fathi, ... The Journal of Clinical Investigation 132 (24), 2022 | 17 | 2022 |
| The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity SL Siekman, T Pongracz, W Wang, J Nouta, PG Kremsner, ... Frontiers in Immunology 13, 993354, 2022 | 10 | 2022 |
| Codiversification of gut microbiota with humans TA Suzuki, JL Fitzstevens, VT Schmidt, H Enav, KE Huus, ... Science 377 (6612), 1328-1332, 2022 | 81 | 2022 |
| Humoral antimalaria immune response in Nigerian children exposed to helminth and malaria parasites S Adukpo, A Adedoja, M Esen, M Theisen, F Ntoumi, O Ojurongbe Frontiers in Immunology 13, 979727, 2022 | 1 | 2022 |
| A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection B Mordmüller, Z Sulyok, M Sulyok, Z Molnar, A Lalremruata, CL Calle, ... npj Vaccines 7 (1), 100, 2022 | 23 | 2022 |
| Prevalence and impact of SARS-CoV-2 infection on maternal and infant health in African populations: protocol of a multi-centre prospective cohort study (MA-CoV project) M Esen | | 2022 |
| Cellular and antibody response in GMZ2-vaccinated Gabonese volunteers in a controlled human malaria infection trial O Nouatin, J Ibáñez, R Fendel, UA Ngoa, FR Lorenz, JC Dejon-Agobé, ... Malaria Journal 21 (1), 191, 2022 | 4 | 2022 |
| Efficacy, T cell activation and antibody responses in accelerated Plasmodium falciparum sporozoite chemoprophylaxis vaccine regimens J Ibanez, R Fendel, FR Lorenz, P Granados-Bayon, S Brückner, M Esen, ... npj Vaccines 7 (1), 59, 2022 | 6 | 2022 |
